HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia

Allogeneic hematopoietic stem cell transplantation (HSCT) is still needed for many children with very high-risk acute leukemia. An HLA-haploidentical family donor is a suitable option for those without an HLA-matched donor. Here we present outcomes of a novel HLA-haploidentical HSCT (haplo-HSCT) str...

Descripción completa

Detalles Bibliográficos
Autores principales: Massei, M. S., Capolsini, I., Mastrodicasa, E., Perruccio, K., Arcioni, F., Cerri, C., Gurdo, G., Sciabolacci, S., Falzetti, F., Zei, T., Iacucci Ostini, R., Brogna, M., Panizza, B. M., Saldi, S., Merluzzi, M., Tognellini, R., Marchesi, M., Minelli, O., Aristei, C., Velardi, A., Pierini, A., Ruggeri, L., Martelli, M. F., Carotti, A., Caniglia, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919737/
https://www.ncbi.nlm.nih.gov/pubmed/36774432
http://dx.doi.org/10.1038/s41409-023-01911-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919737/
https://www.ncbi.nlm.nih.gov/pubmed/36774432
http://dx.doi.org/10.1038/s41409-023-01911-x

Ejemplares similares